Fiche personne
Coordonnées
Centre Georges-François Leclerc
1 rue du Professeur Marion
BP 77980
21079 DIJON Cedex
03 80 73 75 14
Territoire
Bourgogne
Statut
Hospitalier
Affiliation
Équipes/plateformes
Publications
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
Darbo E, Pérot G, Darmusey L, Le Guellec S, Leroy L, Gaston L, Desplat N, Thébault N, Merle C, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Ranchere-Vince D, Méeus P, Terrier P, Piperno-Neumann S, Collin F, De Pinieux G, Duffaud F, Coindre JM, Blay JY, Chibon F
Cancers (Basel). 2023 01 15;15(2):
Risk factors for febrile urinary tract infection in boys with posterior urethral valves.
Harper L, Botto N, Peycelon M, Michel JL, Leclair MD, Garnier S, Clermidi P, Arnaud AP, Dariel AL, Dobremez E, Faure A, Fourcade L, Boudaoud N, Chaussy Y, Collin F, Huiart L, Ferdynus C, Bocquet V, Sauvat F
Front Pediatr. 2022 09 14;10:971662
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.
Benhaddou A, Gaston L, Pérot G, Desplat N, Leroy L, Le Guellec S, Ben Haddou M, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Le Cesne A, Piperno-Neumann S, Collin F, Firmin N, De Pinieux G, Coindre JM, Blay JY, Chibon F
Sci Rep. 2021 Dec 6;11(1):23429
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.
de Pinieux G, Karanian M, Le Loarer F, Le Guellec S, Chabaud S, Terrier P, Bouvier C, Batistella M, Neuville A, Robin YM, Emile JF, Moreau A, Larousserie F, Leroux A, Stock N, Lae M, Collin F, Weinbreck N, Aubert S, Mishellany F, Charon-Barra C, Croce S, Doucet L, Quintin-Rouet I, Chateau MC, Bazille C, Valo I, Chetaille B, Ortonne N, Brouchet A, Rochaix P, Demuret A, Ghnassia JP, Mescam L, Macagno N, Birtwisle-Peyrottes I, Delfour C, Angot E, Pommepuy I, Ranchere D, Chemin-Airiau C, Jean-Denis M, Fayet Y, Courrèges JB, Mesli N, Berchoud J, Toulmonde M, Italiano A, Le Cesne A, Penel N, Ducimetiere F, Gouin F, Coindre JM, Blay JY,
PLoS One. 2021 ;16(2):e0246958
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas.
Lesluyes T, Baud J, Pérot G, Charon-Barra C, You A, Valo I, Bazille C, Mishellany F, Leroux A, Renard-Oldrini S, Terrier P, Le Cesne A, Laé M, Piperno-Neumann S, Bonvalot S, Neuville A, Collin F, Maingon P, Coindre JM, Chibon F
Mod. Pathol.. 2019 Jun 26;:
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.
Mirjolet C, Merlin JL, Truc G, Noël G, Thariat J, Domont J, Sargos P, Renard-Oldrini S, Ray-Coquard I, Liem X, Chevreau C, Lagrange JL, Mahé MA, Collin F, Bonnetain F, Bertaut A, Maingon P
EBioMedicine. 2019 Feb 28;:
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.
Italiano A, Touati N, Litière S, Collin F, Pourquier P, Gronchi A
Cancer Med. 2018 Apr 15;:
Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.
Penel N, Coindre JM, Giraud A, Terrier P, Ranchere-Vince D, Collin F, Guellec SLE, Bazille C, Lae M, de Pinieux G, Ray-Coquard IL, Bonvalot S, Cesne ALE, Robin YM, Stoeckle E, Toulmonde M, Blay JY
Cancer. 2018 Mar 15;124(6):1179-1187
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, Grünwald V, Gronchi A, van der Graaf W, Wardelmann E, Judson I
Acta Oncol. 2017 Apr;:1-8
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.
Bertucci F, Finetti P, Perrot D, Leroux A, Collin F, Le Cesne A, Coindre JM, Blay JY, Birnbaum D, Mamessier E
Oncoimmunology. 2017 ;6(3):e1278100
[Sarcoma developed in irradiated area: Preliminary results of the SARI trial].
Maingon P, Mirjolet C, Diallo I, Veres C, Collin F, Italiano A, Chibon F, Merlin JL, Coindre JM
Cancer Radiother. 2016 Oct;20(6-7):690-3
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.
Wardelmann E, Haas RL, Bovée JV, Terrier P, Lazar A, Messiou C, LePechoux C, Hartmann W, Collin F, Fisher C, Mechtersheimer G, DeiTos AP, Stacchiotti S, Jones RL, Gronchi A, Bonvalot S
Eur. J. Cancer. 2016 Jan;53:84-95
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.
Bui-Nguyen B, Butrynski JE, Penel N, Blay JY, Isambert N, Milhem M, Kerst JM, Reyners AK, Litiere S, Marreaud S, Collin F, van der Graaf WT
Eur J Cancer. 2015 Jul;51(10):1312-20
[Intra-abdominal soft tissue tumors. What needs to be known to reach the diagnosis with the help of immunohistochemistry, FISH and molecular biology].
Collin F, de Saint Aubain N
Ann Pathol. 2015 Jan;35(1):114-25
Guidelines for time-to-event endpoint definitions in sarcomas and gastro-intestinal stromal tumors (GIST) trials. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Bellera CA, Penel N, Ouali M, Bonvalot S, Casalli PG, Nielsen OS, Delannes M, Litiere S, Bonnetain F, Dabakuyo TS, Benjamin R, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Pechoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijder S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pelissier S
Ann Oncol. 2014 Jul 28. pii: mdu360.
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.
Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, Terrier P, de Montpreville VT, Le Gall F, Hostein I, Lagarde P, Chibon F, Coindre JM
Am J Surg Pathol. 2014 Apr;38(4):461-9
Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.
Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, Blouet A, Chaigneau L, Duffaud F, Piperno-Neumann S, Kurtz JE, Girard N, Collard O, Bompas E, Penel N, Bay JO, Guillemet C, Collin F, Blay JY, Le Cesne A, Thariat J
Eur J Cancer. 2014 Jan;50(1):128-36
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.
Sleijfer S, Gorlia T, Lamers C, Burger H, Blay JY, Le Cesne A, Scurr M, Collin F, Pandite L, Marreaud S, Hohenberger P
Br J Cancer. 2012 Aug 7;107(4):639-45
A desmoid tumour associated with a breast prosthesis.
Gergele F, Guy F, Collin F, Krause D
Diagn Interv Imaging. 2012 Mar;93(3):e200-3
Extra-surrenal retroperitoneal myelolipoma: TDM and IRM aspects.
Butori N, Guy F, Collin F, Benet C, Causeret S, Isambert N
. 2012 Mar;93(3):222-5.
Retroperitoneal extra-adrenal myelolipoma: appearance in CT and MRI.
Butori N, Guy F, Collin F, Benet C, Causeret S, Isambert N
Diagn Interv Imaging. 2012 Mar;93(3):e204-7
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group
Pautier P, Floquet A, Penel N, Piperno-Neumann S, Isambert N, Rey A, Bompas E, Cioffi A, Delcambre C, Cupissol D, Collin F, Blay JY, Jimenez M, Duffaud F
Oncologist. 2012;17(9):1213-20
Trends in survival for patients with metastatic soft-tissue sarcoma.
Italiano A, Mathoulin-Pelissier S, Cesne AL, Terrier P, Bonvalot S, Collin F, Michels JJ, Blay JY, Coindre JM, Bui B
Cancer. 2011 Mar 1;117(5):1049-54
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.
Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, Vince-Ranchere D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A
Nat Med. 2010 Jul;16(7):781-7
Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, Benard J, Forget S, Blanchard C, Domont J, Bonvalot S, Guillou L, Leroux A, Mechine-Neuville A, Schoffski P, Lae M, Collin F, Verola O, Carbonnelle A, Vescovo L, Bui B, Brouste V, Sobol H, Aurias A, Coindre JM
Genes Chromosomes Cancer. 2010 Jun;49(6):560-8.
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Jones HA, Antonini N, Hart AA, Peterse JL, Horiot JC, Collin F, Poortmans PM, Oei SB, Collette L, Struikmans H, Van den Bogaert WF, Fourquet A, Jager JJ, Schinagl DA, Warlam-Rodenhuis CC, Bartelink H
J Clin Oncol. 2009 Oct 20;27(30):4939-47
Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S, Stoeckle E, Collin F, Bui B, Terrier P, Guillou L, Trassard M, Ranchere-Vince D, Gregoire F, Coindre JM
Eur J Cancer. 2009 Aug;45(12):2091-102
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 620
Sleijfer S, Ray-Coquard I, Papai Z, Le Cesne A, Scurr M, Schoffski P, Collin F, Pandite L, Marreaud S, De Brauwer A, van Glabbeke M, Verweij J, Blay JY
J Clin Oncol. 2009 Jul 1;27(19):3126-32
Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database.
Salas S, Bui B, Stoeckle E, Terrier P, Ranchere-Vince D, Collin F, Leroux A, Guillou L, Michels JJ, Trassard M, Valo I, Robin YM, Marques B, Brouste V, Coindre JM
Ann Oncol. 2009 Jun;20(6):1127-35
Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group.
Chbani L, Guillou L, Terrier P, Decouvelaere AV, Gregoire F, Terrier-Lacombe MJ, Ranchere D, Robin YM, Collin F, Freneaux P, Coindre JM
Am J Clin Pathol. 2009 Feb;131(2):222-7.
Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate.
Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY, Hogendoorn PC
Eur J Cancer. 2008 Sep;44(13):1855-60
Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB, Guillou L, Hostein I, Chateau MC, Collin F, Aurias A, Binh BN, Stoeckle E, Coindre JM
Am J Surg Pathol. 2007 Oct;31(10):1557-66.
Translocation-positive low-grade fibromyxoid sarcoma: Clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma - A study from the French Sarcoma Gr
Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marques B, Somerhausen NDA, Keslair F, Pedeutour F, Coindre JM
Am J Surg Pathol. 2007 Sep;31(9):1387-402.
[Plexiform schwannoma of the delto-pectoral area]
Gelly-Marty M, Martin E, Assous D, Cuisenier J, Collin F
Ann Pathol. 2007 Apr;27(2):133-5.
[How to classify a soft tissue sarcoma in 2006].
Coindre JM, Ranchere D, Collin F
Ann Pathol. 2006 Nov;26 Spec No 1:1S98-109.
Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
Coindre JM, Hostein I, Terrier P, Bouvier-Labit C, Collin F, Michels JJ, Trassard M, Marques B, Ranchere D, Guillou L
Cancer. 2006 Sep 1;107(5):1055-64.
Malignant extraovarian endometriosis: a review.
Benoit L, Arnould L, Cheynel N, Diane B, Causeret S, Machado A, Collin F, Fraisse J, Cuisenier J
Eur J Surg Oncol. 2006 Feb;32(1):6-11
[Soft tissue sarcomas: current data in the field of pathology].
Collin F, Gelly-Marty M, Bui Nguyen Binh M, Coindre JM
Cancer Radiother. 2006 Feb-Mar;10(1-2):7-14
[Soft tissue sarcomas: update on molecular data].
Bui Nguyen Binh M, Collin F, Coindre JM
Cancer Radiother. 2006 Feb-Mar;10(1-2):15-21
The role of surgery and treatment trends in uterine sarcoma.
Benoit L, Arnould L, Cheynel N, Goui S, Collin F, Fraisse J, Cuisenier J
Eur J Surg Oncol. 2005 May;31(4):434-42.
Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM, Hostein I, Maire G, Derre J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A
J Pathol. 2004 Jul;203(3):822-30.
Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.
Trassard M, Le Doussal V, Hacene K, Terrier P, Ranchere D, Guillou L, Fiche M, Collin F, Vilain MO, Bertrand G, Jacquemier J, Sastre-Garau X, Bui NB, Bonichon F, Coindre JM
J Clin Oncol. 2001 Jan 15;19(2):525-34.
